Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Biomab EGFR 200mg Injection
Manufacturer/Marketed By : ERIS LIFESCIENCES LIMITED
$655.32 $458.73
Biomab EGFR 200mg Injection consists of the active Nimotuzumab. It is a monoclonal antibody used in cancer treatment. It has been approved for the treatment of head and neck cancer,...
NIMOTUZUMAB
Active Pharmaceutical Ingredient
Biomab EGFR 200mg Injection
$655.32
$458.73
Biomab EGFR 200mg Injection consists of the active Nimotuzumab. It is a monoclonal antibody used in cancer treatment. It has been approved for the treatment of head and neck cancer, as well as for certain types of brain cancer. This medication is typically used with other cancer treatments, such as chemotherapy and radiation therapy. The Biomab egfr 200mg Injection effectively improves overall survival and disease-free survival in some cancer patients. However, like all cancer treatments, it can have side effects, including allergic reactions, skin rashes, and flu-like symptoms. transplant. There are no absolute contraindications to Biomab EGFR 200mg Injection, but there are some precautions and potential contraindications to consider. For example, patients with a history of severe allergic reactions or hypersensitivity to it or its components should not receive the medication. Additionally, patients with certain medical conditions, such as severe liver or kidney disease, may need to be monitored closely or have their dosages adjusted.
Active Pharmaceutical Ingredient
Uses
• Head and neck cancer
• Certain types of brain cancer
• Esophageal cancer
Benefits
The therapeutic effect of Biomab EGFR 200mg Injection is primarily focused on its ability to target and bind to the epidermal growth factor receptor (EGFR) found on many cancer cells. Doing so can block the growth and spread of cancer cells, ultimately leading to improved patient outcomes. One of the advantages is its targeted therapy approach, which allows it to target cancer cells while minimising damage to healthy cells specifically. This can help to reduce side effects and improve the overall quality of life for cancer patients undergoing treatment.
Side Effects
Like all medications, Biomab EGFR 200mg Injection can cause side effects, although not everyone who takes it will experience them.
Most Common Side Effects
• Skin rash
• Diarrhea
• Nausea and vomiting
• Fatigue
• Headache
• Fever
• Pain at the injection site
Common Side Effects
• Allergic reactions
• Difficulty breathing
• Swelling of the face or throat or hives
• Infusion reactions (fever, chills, or low blood pressure)
• Chest pain
• Irregular heartbeat
• Lung problems (cough or shortness of breath)
• Liver problems (jaundice or abdominal pain)
How To Use
Biomab EGFR 200mg Injection is an injectable medication that a healthcare professional administers. It is typically given as an intravenous injection. The dose and frequency will depend on the type of cancer being treated, the patient's overall health, and other medications the patient may be taking. If you miss a dose, contact your healthcare provider as soon as possible. Your healthcare provider may recommend rescheduling your next dose or adjusting your dosing schedule. Do not double the dose to make a missed dose.
Safety Advice
• Breast Feeding: There is limited information on whether Biomab EGFR 200mg Injection passes into breast milk, so it is important to talk to your healthcare provider before breastfeeding.
• Alcohol: There are no known interactions between Biomab EGFR 200mg Injection and alcohol. So it is better to consult a healthcare provider.
• Liver: Biomab EGFR 200mg Injection is primarily metabolised in the liver, so inform your healthcare provider if you have any liver problems or diseases. In some cases, it may cause liver toxicity, which can lead to elevated liver enzymes or other liver problems.
• Lungs: If you have a pre-existing lung condition or disease, such as chronic obstructive pulmonary disease (COPD) or asthma, inform your healthcare provider before starting treatment. In some cases, it may cause lung toxicity, leading to symptoms such as cough, shortness of breath, wheezing, or chest pain.
• Driving: Patients receiving Biomab EGFR 200mg Injection should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Biomab EGFR 200mg Injection is not safe for an unborn baby. Therefore, it is not recommended for pregnant women.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.